Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-nave controls

By Borrow R.   Southern J.   Andrews N.   Peake N.   Rahim R.   Acuna M.   Martin S.   Miller E.   Kaczmarski E.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3043-3050

Elsevier

Access to resources Recommend Favorite

Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial

By Choo S.   Zuckerman J.   Goilav C.   Hatzmann E.   Everard J.   Finn A.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2686-2692

Elsevier

Access to resources Recommend Favorite

Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain

By Salleras L.   Domnguez A.   Cardenosa N.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 725-728

Elsevier

Access to resources Recommend Favorite

Salivary antibody response to vaccination with meningococcal A/C polysaccharide vaccine in previously vaccinated and unvaccinated Gambian children

By Nurkka  

Vaccine, Vol. 19, Iss. 4, 2000-10 ,pp. : 547-556

Elsevier

Access to resources Recommend Favorite

A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers

By Blum M.D.   Dagan R.   Mendelman P.M.   Pinsk V.   Giordani M.   Li S.   Bohidar N.   McNeely T.B.  

Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. : 2359-2367

Elsevier

Access to resources Recommend Favorite